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Purpose. To evaluate and compare the mesenteric and bowel wall changes during Crohn’s disease (CD) on ultrasonography (US)
Strain Elastography (SE) and Enterography Magnetic Resonance Imaging (E-MRI). Methods. From July 2014 to September 2016,
35 patients with ileocolonoscopy diagnosis of CD were prospectively examined with E-MRI and in the same time with US and SE.
Results. A total of 41 affected bowel segments and 35 unaffected bowel segments in 35 patients were evaluated. US-SE color-scale
coding showed a blue color pattern in the fibroticmesentery and bowel wall in 15 patients and a green color pattern in the edematous
ones in 20 patients. The signal of the bowel wall and mesenteric fat was iso/hypointense on T2-weighted sequence in the fibrotic
pattern (23/35 and 12/35 patients) and hyperintense in the edematous pattern (12/35 and 23/35 patients). Mean ADC values were,
respectively, 2,58±0,33 × 10−3 for the fibrotic mesentery and 2,14±0,28 × 10−3 for edematous one.There was a statistical correlation
between US-SE color-scale and T2 signal intensity and between the US-SE color-scale and ADC maps. Conclusions. US-SE, ADC,
and signal intensity on T2-weighted sequences on MR prove to be useful tools for the evaluation of CD pattern.
1. Introduction
Crohn’s disease (CD) is relapsing and remitting formof trans-
mural inflammatory bowel disease that affects the gastroin-
testinal and diffuses into the mesenteric fat [1].The incidence
and prevalence are increasing with time and in many regions
around the world with highest reported prevalence in Europe
and North America [2].
Although endoscopy with biopsy remains the gold stan-
dard for CD’s diagnosis, imaging plays a central role in the
assessment of intestinal and extraintestinal involvement, in
the surveillance and assessment of response to treatment, and
in the detection of complications [1].Many imaging tools help
in identifying bowel wall thickening, hyperperfusion, and
active inflammation, as Enterography Magnetic Resonance
Imaging (E-MRI) and Contrast-Enhanced Ultrasonography
[3–5]. On the contrary, the distinction between inflammation
and fibrosis may still be tricky. However, this differentiation
has a great impact on patients’ management: fibrotic pattern
usually needs endoscopic dilatation or surgery, while active
inflammation pattern responds to the conservatory treatment
[1].
The evaluation of elasticity at ultrasonography (US),
through Strain Elastography (SE), is a noninvasive method
that allows assessing tissue stiffness, and it is already used
for the evaluation of liver, breast, and thyroid diseases
[6]. SE is able to quantify tissue elasticity simultaneously
during B-mode ultrasound examination and elasticity values
can be on the basis of anatomical information. SE allows
seeing real-time visualization of an image on the display
screen and the stress is applied manually via a hand-
held ultrasound transducer, which provides low-frequency
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compression. In particular, SE provides elastography colori-
metric maps according to the degree of stiffness.
Recent clinical studies reported promising results for
distinguishing inflamed from fibrotic bowel by using the US
elastography [7–10].The overwhelmingmajority of investiga-
tions evaluating the radiological assessment of inflammatory
bowel disease lack an appropriate study of the mesenteric
fat. To our knowledge, SE of the mesenteric fat has not
been studied in in vivo human CD and in particular two
SE and E-MRI techniques have not been compared yet for
the differentiation between edematous and fibrotic changes
in CD.
The purpose of our study was to assess whether SE and
DWI could be used detect mesenteric and bowel wall fibrosis
and differentiate it from edematous/inflammatory changes.
2. Materials and Methods
2.1. Patients. The institutional review board approved this
prospective study. All patients gavewritten informed consent.
From July 2014 to September 2016, 35 patients (mean age
33,12; range 9–90; 16/19 F/M) were selected for this study,
and all patients had a previous ileocolonoscopy diagnosis
of CD. Patients were categorized according to the Montreal
Classification [11]. Demographic data of the patients were
collected.
Typical E-MR imaging appearance of CD was defined as
bowel wall thickening (>1 cm) and bowel wall enhancement,
while the extramural disease was defined as fibrofatty prolif-
eration as thickening of extramural fat, which separates bowel
loops and the vascular engorgement (comb sign) [1].
Typical US imaging appearance of CD was defined as
bowel wall thickening (>3mm), losing or preserving the
gut signature, while the extramural disease was defined as
perienteric fluid and creeping fat which separates bowel loops
[1].
2.2. MR Imaging Protocol. All 35 patients were imaged with
a 1.5T MR imaging unit (Achieva, Philips Healthcare, Best,
Netherlands). A dedicated abdominal multichannel surface
coil was used for all patients. All patients were scanned
after oral administration of 1.5–2 L of polyethylene glycol
solution,Moviprep (Norgine, Amsterdam,TheNetherlands),
or Selg-Esse 1000 (PROMEFARM, Milan, Italy), as oral
contrast agent over the course of 30 minutes. Imaging
protocol included axial precontrast images acquired with
T2-weighted fast-spin echo sequence (TR/TE, 4000/76ms;
section thickness 5-6mm) and T1-weighted axial in-phase
and out-of-phase gradient-recalled-echo sequence (TR/TE,
140/2.2–4.4ms; section thickness, 5-6mm). Dynamic studies
were performed with three-dimensional fat- suppressed T1-
weighted gradient echo sequence (TR/TE, 3.8/1.2ms; FA 12∘ ;
slice thickness: 4.4mm; intersection gap 2mm; FOV: 44 cm;
matrix 256 × 256) by using a bolus tracking system. Images
were acquired on the coronal plane immediately before
and after intravenous injection of either 0.1mmol/kg body
weight of gadoterate meglumine (Dotarem, Guerbet GmbH,
Sulzbach, Germany) at 2mL/s or 0.1mmol//kg body weight
through a 20-gauge intravenous catheter bymeans of a power
injector (Medrad Spectris Solaris EP MR Injection System;
Bayer Healthcare), followed by a 20-mL saline flush at the
same injection rate. Scanning delays after automatic detection
of contrast bolus were 18, 60, and 180 s, respectively for the
acquisition of the arterial, portal venous, and three-minute
phase. Before contrast-medium injection, 20mg hyoscine-N-
butylbromide (Buscopan, Boehringer, Ingelheim, Germany)
was intravenously injected unless contraindicated (e.g., his-
tory of cardiac arrhythmia, narrow angle glaucoma, or pro-
statism). Diffusion-weighted (DWI) single-shot echo planar
images with 𝑏 values of 0, 600, and 800 s/mm2 were acquired
with free breathing method using slice thickness of 8mm.
2.3. US-SE Imaging Protocol. All US examinations were
conducted by (blinded) abdominal staff radiologist with 15
years of experience and another (blinded), in his fifth year
of training, respectively, by using a Samsung RS80A with
Prestige (Samsung Medison Co. Ltd) that included the EZU-
TE5 option. All patients underwent abdominal US examina-
tion soon after the E-MR. B-mode US was conducted with a
linear-array transducer (EUP-L74M, 5–13MHz, 50 3 10mm;
Samsung) equipped with ElastoScan technology.
For each patient, B-mode US coronal and axial images
were obtained of the last ileal loop and of the relative
perimesenteric fat. In the same locations, the US-SE was per-
formed according to manufacturer guidelines with the same
transducer, and relative strain measurements were obtained
from the perimesenteric fat.
For every patient, B-mode US coronal and axial images
were obtained of the ileal loop and of the relative perime-
senteric fat in the upper-left abdominal location. In the same
locations, the US-SE was performed according to manufac-
turer guidelines with the same transducer, and relative strain
measurements were obtained from the perimesenteric fat.
2.4. Image Analysis. All MR images were evaluated on a
commercial picture archiving and communication system
station (PACS-Impax,Agfa-Gevaert). An acute inflammatory
change of CD appearance was defined as a bowel wall
thickening greater than 3mm, hyperintense bowel wall on
T2 FAT-SAT-weighted images and increased enhancement
on postcontrastographic T1-weighted images as stratified
contrast enhancement pattern or transmural enhancement
pattern, while the mesenteric is characterized by edema
as an intermediate to high signal intensity on T2 FAT-
SAT-weighted images and by the presence of inflammatory
mesenteric lymph nodes.
While a fibrotic change of CD appearance was defined
as a bowel wall thickening greater than 3mm, hypointense
bowel wall on T2 FAT-SAT-weighted images and increased
enhancement on postcontrastographic T1-weighted images
were defined as low level inhomogeneous contrast enhance-
ment pattern. The mesenteric is characterized by creeping
fat as an increased mesenteric fat producing a mass effect
which presented a slightly decreased signal intensity on
T2 FAT-SAT-weighted images [1]. Two observers (blinded),
an abdominal radiologist with 15 years of experience and
another, in his fifth year of training, graded jointly their
degree of confidence in diagnosing the presence of an
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Figure 1: Longitudinal US-scan of the last ileal loop in a 33-year-old male shows wall thickening with prominence of submucosa and
hyperechoic appearance of perivisceral fat. The gray scale (a) findings and US-SE (b) aspect performed at this level are suggestive for active
inflammation pattern. The MR study ((c), (d), and (e)) confirmed these suspicions: T2 weighted coronal view revealed hyperintensity of the
bowel wall, T1 weighted axial postcontrast showed stratification of the bowel wall, DWI with 800 𝑏 value showed hyperintensity of the bowel
wall, and an aspect of the last ileal loop is very similar with US findings.
acute inflammatory or fibrotic appearances in volumetric T1
weighted GRE images on postcontrastographic phases, in T2
FAT-SAT-weighted images and DWI- weighted images (1: no
changes; 2: probably acute inflammatory; 3: definitely acute
inflammatory; 4: probably fibrotic; 5: definitely fibrotic). If
there was any discordance, the determination was reached by
means of consensus. Disagreements among the three readers
were considered relatively few and minor. Observers also
analyzed the number and diameter of bowel wall lesions and
the presence of any complications.
Observers analyzed the US-SE of the patients and they
categorized jointly their degree of confidence in diagnosing
the presence of an acute inflammatory or fibrotic appearances
of the mesenteric fat in colorimetric map images (red: no
changes; yellow: probably acute inflammatory; green: defi-
nitely acute inflammatory; light blue: probably fibrotic; blue:
definitely fibrotic); we followed the methods of Dioguardi
Burgio et al. 2016 [12].
2.5. Statistical Analysis. Values are expressed asmean (range)
or percentages, as appropriate. The Fisher exact test was used
to compare differences in discrete or categorical variables
and Student’s 𝑡-test was used to compare differences between
mean values. Statistical significance was defined as𝑝 less than
0.05. All statistical tests were 2-sided. All statistical analyses
were performed by using GraphPad Prism for Macintosh
version 6 software (GraphPad Software Inc., La Jolla, CA,
USA). Graphs were created by using the same software.
3. Results
Affected and unaffected mesenteric areas and bowel walls
were detected on E-MRI and US-SE. A total of 41 affected
bowel segments (35 ileum and 6 colon segments) and 35
unaffected bowel segments (35 ileum) in 35 patients were
evaluated. In 29 patients the ileum was affected while in
6 patients the ileum and colon were involved. The affected
segment’s extension mean was 8,1 cm (range 2,1 cm–25,2 cm)
and thewall thickeningmeanwas 1 cm (range 0,6 cm–1,3 cm).
We found 9 stricture segments while intrawall abscess and
ileoileal fistulas were detected in 11 and 7 patients, respec-
tively.
A fibrotic mesenteric and bowel wall change were present
on E-MRI andUS-SE in 12/35 (34,29%), 23/35 (65,71%), 15/35
(42,85%), and 20/35 (57,15%), respectively, while an acute
inflammatorymesenteric and bowel wall changewere present
on E-MRI andUS-SE in 23/35 (65,71%), 12/35 (34,29%), 20/35
(57,15%), and 15/35 (42,85%), respectively (Figures 1 and 2).
In all unaffected bowel segments and relative perimesen-
teric fat, the US-SE color- scale coding showed a red and/or
yellow color variation. Moreover, the signal of the bowel
wall andmesenteric fat were iso/hypointense on T2-weighted
sequence in the fibrotic pattern (23/35 and 12/35 patients)
and hyperintense in the edematous pattern (12/35 and 23/35
patients). The correlation between US-SE color-scale and T2
signal intensity was statistically significant (p < 0,05).
There was a significant diffusion restriction in 18 patients
with CD in the active phase (mean ADC values for the
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Figure 2: Transverse US-scan of the last ileal loop in a 26-year-old female shows wall thickening in which stratification was completely lost
and there is hypoechoic appearance of perivisceral fat. The gray scale (a) findings and US-SE (b) aspect performed at this level are suggestive
for fibrotic pattern. The MR study ((c) and (d)) confirmed these suspicions: T2 weighted coronal view revealed hypointensity of the bowel
wall, T1 weighted coronal postcontrast showed enhancing of the bowel wall without stratification.
fibrotic mesentery: 2,58 ± 0,33 × 10−3, mean ADC values
for edematous mesentery: 2,14 ± 0,28 × 10−3). There was
a statistical correlation between the US-SE color-scale and
ADC maps (p < 0,05). However, 3/35 patients were defined
as acute inflammatory pattern by US-SE but E-MRI through
both T2-weighted sequence and ADCmap classified them in
fibrotic pattern.
No significant diffusion restriction was encountered in
35/35 unaffected bowel segments and relative perimesenteric
fat (mean ADC values: 2,92 ± 0,15 × 10−3). Also we found
a statically significant correlation between the presence of
enlarged lymph nodes and the edematous change (p < 0,05)
and between the presence of stricture and the fibrotic changes
(p < 0,05).
However, there was a significant difference between the
control and the study group. According to the data in the
control group there was not a significant diffusion restriction
and there were an isointense T2 signal and a predominantly
green USE color-scale of the mesentery and bowel wall.
4. Discussion
In the management of CD, key important tools to guide
therapeutic choices are the assessment of disease activity and
the differentiation between inflammatory/edematous and
fibrotic patterns [1]. MRI examination through DWI helps
in the detection of active CD, showing high signal on DWI
sequences, and in the differentiation between fibrotic and
edematous changes of bowel loops, showing higher ADC
values in case of fibrotic changes compared to the edematous
mesentery, and of this latter one compared to the normal
pattern.
The main guiding tool for patient management is
the differentiation between active edematous inflammation,
which needs just conservatory treatment, and progression
towards fibrosis, which usually needs endoscopic dilatation
or surgery [7]. Thus, the main goal of our study was to
evaluate the role of US/SE itself and in comparison to
E-MRI in the differentiation of fibrotic and edematous
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pattern of CD. Our results show that, on E-MRI, fibrotic
changes of the mesentery are characterized by higher ADC
values and lower T2 signal compared to the edematous
mesentery.
MRI is useful in the differentiation between active inflam-
mation and fibrostenotic disease through the evaluation
of mural thickness, stratification and enhancement, mural
edema, mesenteric vascularity/adenopathy, fibrofatty prolif-
eration, and the evaluation of the presence of complications.
Rimola et al. classified the different stages of inflammation
and proved that MRI may accurately detect severe fibro-
sis through the evaluation of the enhancement pattern of
affected bowel loop [13]. In a meta-analysis of seven studies
(140 patients) [14], MRI correctly graded disease activity in
91% of cases with frank disease.
However, MRI is time and money consuming and not
widely available. US, which is more widely available and less
time consuming thanMRI, may evaluate the localization and
the length of the affected intestinal segments in CD (bowel
thickening from the superficial layer which is hyperechoic
to the mucosal layer > 5mm in a nondistended bowel,
>3mm in a distended bowel; loss of multilayer pattern is
sign of active inflammation) [5]. Concerning the mesenteric
changes, it may assess the presence of creeping fat as an
echogenic area separating bowel loops representing the fibro-
fatty proliferation of adipose tissue that extends around active
inflammation.Our results proved that fibrotic and edematous
changes of the bowel and mesentery in CD may be done
noninvasively through SE, which is a noninvasive method for
evaluating tissue stiffness. SE has initially been used to assess
breast, thyroid, and liver lesions, but in the last decade this
method was found to have many applications in a wide range
of fields [6, 15, 16].
At elastography red means soft while blue means hard:
so the nearer you are to the blue the nearer you are to the
fibrosis while the nearer you are to the red the nearer you
are to the normal pattern. Hence, it is possible to grade
the fibrofatty changes of the mesentery from normal (grades
1 and 2) throughout grade 3 (green) edematous changes
to blue (grades 4 and 5) which indicates fibrotic changes
[17]. In our study, concerning the changes in the stiffness at
SE, the pathological ileal loop showed edematous changes
(grade 3, green) in 20 patients and fibrotic changes in 15
patients (grades 4 and 5, light and dark blue), while all the
nonpathological ileal lops did not show any oedematous or
fibrotic change (grades 1 and 2, red and yellow color). These
differences proved to be statistically significant in the iden-
tification of the pathological loop and in the differentiation
of the fibrotic and edematous changes. A close look at our
data shows that in 3 patients US-SE did not correctly grade
as fibrotic the bowel and mesenteric changes. This could be
explained by the fact that a qualitative assessment of US-SE
leads to incomplete separation of edematous and low-fibrosis
pattern and of high- and low-fibrosis pattern, while on MRI
the combination of the quantitative datum of ADC map and
the T2 signal allows a more precise categorization. Although
this overlap is minimal, a quantitative assessment through
shear waveUS elastography could theoretically overcome this
limit.
Few studies in the literature investigated the possibility of
evaluating the bowel by contrast-enhanced ultrasonography
by use of oral (SICUS) or intravenous (CEUS) contrast
agents. SICUS has emerged as a valuable and radiation-free
technique [18] in the evaluation of bowel wall in CDwhile the
use of CEUS is important to monitor response to therapies
[19, 20].
Few studies in the literature investigated the possibility
of evaluating the bowel by US- elastography [7–10, 17], but,
to date, this imaging technique has not been introduced
in the common diagnostic strategies of CD patients yet
[5]. Dillman et al. demonstrated that shear wave imaging
accurately distinguishes fibrotic bowel in a CD animal model
[8] and in ex vivo bowel wall loops [7].
Our study revealed a statistically significant correlation
between the MRI and the US-SE findings during the eval-
uation of bowel wall and mesenteric changes. In particular,
the bowel wall thickness and stratification pattern can be seen
on US and the additional SE score gives information on the
associated mesenteric changes.Themesenteric white adipose
tissue, which was long considered as the “anatomists’ Cin-
derella,” is now recognized as amultifunctional organ.The fat
abnormalities in CD correlate with transmural inflammation,
with a significant relationship between fat wrapping and
other connective tissue changes, including fibrosis, muscular
hypertrophy, and stricture formation. As demonstrated by
our study, the evaluation of the mesenteric changes in CD
through US-SE can be considered an additional tool in
the differentiation of the edematous or fibrotic changes, in
order to distinguish acutely inflamed from fibrotic intestine
in patients with CD. Increased ADC values and blue color
in inflammatory stricture bowel is likely due to differences
in bowel wall collagen and water content compared to
edematous bowel wall. US strain imaging quantifies the
“hardness” or “softness” of a tissue as a function of tissue
compressibility. This differentiation is mandatory for the
therapeutic management. A strength of our evaluation is
surely the performance of SE soon after E-MRI, and thus
the effect of the spasmolytic agent may have helped in the
evaluation of the bowel wall and mesentery stiffness. Many
limits pertain to our analysis. Firstly, we performed just
a qualitative evaluation of edematous or fibrotic changes
at SE. Actually, quantitative and comparative analyses may
be performed through newly available software programs
and these could better demonstrate the correlation between
MRI and SE findings. Moreover, considering that there is
minimal overlap between edematous and fibrotic pattern,
quantitative method could turn to be useful in the differ-
entiation and could help in identifying a possible cut-off
value in KPascal between affected and unaffected mesentery
and between fibrotic and edematous mesentery. Another
limitation of our study is the small number of patients
enrolled and thus the small number of bowel wall loops
evaluated and a low number of patients for an accurate
comparison between elastography and MR. Finally, intrinsic
limitations pertain to US. For example, obesity in patients
with CDmight impair the applicability of SE in these patients
by causing inadequate penetration of the high-frequency
transducers.
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US: Ultrasonography
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DWI: Diffusion-weighted imaging
ADC: Apparent diffusion coefficient
E-MRI: Enterography Magnetic Resonance Imaging.
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